Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
MNTR Mentor Capital	$0.05 +4.7%	$0.05	$0.03 ▼ $0.11	$1.15M	-0.67	19,329 shs	13,700 shs
NSAV Net Savings Link		$0.00	$0.00 ▼ $0.01	$710K	3.22	409,542 shs	360 shs
PKPH Peak Pharmaceuticals	$0.70 -10.3%	$1.00	$0.52 ▼ $9.12	$274K	0.54	9,053 shs	601 shs
PVSP Pervasip	$0.00	$0.00	$0.00 ▼ $0.00	$1.09M	-0.38	4.80 million shs	32.86 million shs

The Best Nuclear Energy Stocks to Buy

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
MNTR Mentor Capital	0.00%	+3.48%	-6.30%	+44.57%	-22.15%
NSAV Net Savings Link	0.00%	0.00%	0.00%	0.00%	-97.78%
PKPH Peak Pharmaceuticals	0.00%	-5.41%	-30.00%	-72.00%	-68.18%
PVSP Pervasip	0.00%	+25.00%	0.00%	-33.33%	0.00%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
MNTR Mentor Capital	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
NSAV Net Savings Link	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
PKPH Peak Pharmaceuticals	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
PVSP Pervasip	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating	Consensus Price Target	% Upside from Current Price
MNTR Mentor Capital	N/A	N/A	N/A
NSAV Net Savings Link	N/A	N/A	N/A
PKPH Peak Pharmaceuticals	N/A	N/A	N/A
PVSP Pervasip	N/A	N/A	N/A

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
MNTR Mentor Capital	$7.71M	0.15	N/A	N/A	$0.13 per share	0.41
NSAV Net Savings Link	N/A	N/A	N/A	N/A	N/A	N/A
PKPH Peak Pharmaceuticals	N/A	N/A	N/A	N/A	N/A	N/A
PVSP Pervasip	$15.77M	0.07	N/A	N/A	N/A	∞

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
MNTR Mentor Capital	-$840K	-$0.03	N/A	∞	N/A	N/A	-22.97%	-19.23%	N/A
NSAV Net Savings Link	N/A	N/A	0.00	N/A	N/A	N/A	N/A	N/A	N/A
PKPH Peak Pharmaceuticals	-$160K	N/A	0.00	∞	N/A	N/A	N/A	-159.55%	N/A
PVSP Pervasip	$16.92M	N/A	0.00	∞	N/A	N/A	-11.27%	26.60%	N/A

Latest PKPH, PVSP, MNTR, and NSAV Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
8/13/2025	Q2 2025	MNTR Mentor Capital	N/A	-$0.01	N/A	-$0.01	N/A	$0.08 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
MNTR Mentor Capital	N/A	N/A	N/A	N/A	N/A
NSAV Net Savings Link	N/A	N/A	N/A	N/A	N/A
PKPH Peak Pharmaceuticals	N/A	N/A	N/A	N/A	N/A
PVSP Pervasip	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
MNTR Mentor Capital	N/A	36.84	36.84
NSAV Net Savings Link	N/A	N/A	N/A
PKPH Peak Pharmaceuticals	N/A	0.15	0.15
PVSP Pervasip	N/A	N/A	N/A

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
MNTR Mentor Capital	N/A
NSAV Net Savings Link	N/A
PKPH Peak Pharmaceuticals	N/A
PVSP Pervasip	N/A

Insider Ownership

Company	Insider Ownership
MNTR Mentor Capital	23.73%
NSAV Net Savings Link	0.19%
PKPH Peak Pharmaceuticals	18.40%
PVSP Pervasip	9.20%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
MNTR Mentor Capital	2	21.69 million	16.54 million	Not Optionable
NSAV Net Savings Link	1	7.10 billion	7.09 billion	Not Optionable
PKPH Peak Pharmaceuticals	1	392,000	320,000	Not Optionable
PVSP Pervasip	3	5.43 billion	4.93 billion	Not Optionable

PKPH, PVSP, MNTR, and NSAV Headlines

Recent News About These Companies

Pervasip Announces First Quarter Financials

April 23, 2024 | globenewswire.com

Pervasip Announces Financial Results for Fiscal Year 2023

February 29, 2024 | globenewswire.com

Pervasip Announces Successful Completion of Pcaob Audit

January 27, 2024 | finance.yahoo.com

Pervasip Announces Third Quarter Financials

October 17, 2023 | finance.yahoo.com

Pervasip Announces Second Quarter Financials

July 18, 2023 | finance.yahoo.com

Pervasip Announces Expansion Into California Market

June 29, 2023 | finance.yahoo.com

PERVASIP ANNOUNCES FIRST OREGON ARTIZEN TOP-SHELF FLOWER HARVESTS FOR AUGUST

June 20, 2023 | finance.yahoo.com

PERVASIP ANNOUNCES ENTRY INTO $1.1B OREGON RECREATIONAL CANNABIS MARKET

April 19, 2023 | finance.yahoo.com

Pervasip Announces First Quarter Financials

April 17, 2023 | finance.yahoo.com

Pervasip is Entering the $8 Billion Global Nano Market With Artizen Nano and Acquires Slurped

April 5, 2023 | finance.yahoo.com

Pervasip Announces Financial Results for Fiscal Year 2022

March 1, 2023 | finance.yahoo.com

Pervasip Announces Artizen Spin Off

January 17, 2023 | finance.yahoo.com

Pervasip Announces 3rd Quarter Financials

October 18, 2022 | finance.yahoo.com

Pervasip Q3 Revenue Grows 17% Sequentially, Here Are The Details

October 18, 2022 | benzinga.com

Pervasip Announces Strategic Acquistion and $4 Million in New Revenues

October 10, 2022 | finance.yahoo.com

Pervasip Announces $1.6 Million in August Revenues and 3rd Quarter Guidance

September 13, 2022 | finance.yahoo.com

24 MONTH ROADMAP TO $50 MILLION IN SALES

September 6, 2022 | finance.yahoo.com

Restructuring Leading to $500,000 in Annual Cost Savings Plus New Customer Contracts

August 4, 2022 | finance.yahoo.com

Artizen Succesfully Launched New Product Line

July 28, 2022 | finance.yahoo.com

Pervasip Announces 2 Billion Authorized Share Reduction and no Reverse Splits for 5 Years

July 21, 2022 | finance.yahoo.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

PKPH, PVSP, MNTR, and NSAV Company Descriptions

Mentor Capital OTCMKTS:MNTR

$0.05 +0.00 (+4.74%)

As of 03:30 PM Eastern

Mentor Capital, Inc. is a private equity firm specializing in acquisitions and emerging growth investments. The firm provides passive equity funding and liquidity to smaller companies and owners in the medical, marijuana and social use cannabis companies. It invests in shelf IPO's and public and private companies and seeks to provide public market access to owners of small private companies. The firm specializes in pre-IPO investments in Cannabis companies. It seeks to invest in energy sector of oil and gas, coal, uranium. In case of shelf IPO's, the firm prefers to invest in companies with sales greater than $40 million. It prefers to take significant position in its portfolio companies. The firm invests only in companies that have earnings. Mentor Capital, Inc. was founded in 1985 and is based in Plano, Texas.

Net Savings Link OTCMKTS:NSAV

Net Savings Link, Inc. operates as a cryptocurrency, blockchain, and digital asset technology company. It holds interests in Cryptocurrency Trading Platform based on Artificial Intelligence (AI) and offers a range of trading services, such as portfolio management and price search function. This platform supports various cryptocurrency exchanges. The company is based in London, the United Kingdom.

Peak Pharmaceuticals OTCMKTS:PKPH

$0.70 -0.08 (-10.26%)

As of 08/15/2025

Peak Pharmaceuticals, Inc. manufactures and markets pharmaceutical level products containing phytocannabinoids, an abundant and pharmaceutically active component of industrial hemp for the prevention and alleviation of various conditions and diseases. The company was founded on December 18, 2007 and is headquartered in Scottsdale, AZ.

Pervasip OTCMKTS:PVSP

$0.0002 0.00 (0.00%)

As of 01:13 PM Eastern

Pervasip Corporation focuses on developing cloud-based applications to monitor and control greenhouse facilities. It intends to develop and deliver products and technologies to agricultural markets; develop scientific methods for the analysis of cannabinoids in flowers, concentrates, and edibles; and assist medical marijuana specialty production facilities to regulate, calculate proper dosage, and understand the importance of consistency in product. The company was formerly known as eLEC Communications Corp. and changed its name to Pervasip Corp. in December 2007. Pervasip Corp. was founded in 1964 and is based in White Plains, New York.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time